Regeneron will be responsible for funding preclinical, clinical and commercial development for any ModeX product it chooses to advance from the research pact, with ModeX eligible for milestone ...
Regeneron has given up on a CAR-T candidate acquired from 2seventy bio last year before it entered the second part of a phase 1/2 lymphoma study. | Regeneron has given up on a CAR-T candidate acquired ...
Potential assets would target multiple biological pathways in a single molecule Total value of the partnership potentially exceeds $1 billion if ...
The Journal News on MSN
Regeneron to sell off Suffern site, former home of Avon, after nixing Rockland expansion
Avon, then known as California Perfume Co., moved its laboratory and manufacturing to Suffern in 1897. The cosmetics behemoth ...
Regeneron has once again received a complete response letter (CRL) from the US Food and Drug Administration (FDA) for the ...
Tarrytown-based Regeneron would acquire 23andMe for $256 million under the deal that is pending approval by bankruptcy court and regulators. New York-based biotech giant Regeneron Pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback